FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia
Go back to FDA approves Ionis drug Tryngolza for severe hypertriglyceridemia| (NASDAQ: IONS) | Delayed: 44.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.90 | 52 Week High | $62.68 | |||
| Open | $44.90 | 52 Week Low | $19.59 | |||
| Day High | $44.90 | P/E | N/A | |||
| Day Low | $44.90 | EPS | $0.00 | |||
| Volume | 5,138 | |||||

